Skip to content

DR. JASPER VICTOOR, PATHOLOOG-ANATOOM

Active
Private limited companyfounded 20215 yrs activeVossenlaan 19, 2340 Beerse, BelgiumKBO/BCE: BE 0770.756.159
Summary

The computed 12-month bankruptcy probability of DR. JASPER VICTOOR, PATHOLOOG-ANATOOM is 2.3% (moderate). The 2025 annual accounts show equity of €1k and a net result of €257k. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
48 / 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency25▼-75
Growth58▼-20
Track record94
Bankruptcy probability, 12 months
2.3% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 5 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
0.2%
Return on assets
39.1%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-06-2026, 51 days ahead of the deadline.
NBB · 4 filings
Deviation from the deadline
2025
51 d early
2024
35 d early
2023
55 d early
2022
55 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€1k▼ 99.9%
2024 · €869k
2022: €242k 2023: €543k 2024: €869k
2022 → 2025
Total assets
€657k▼ 26.5%
2024 · €894k
2022: €293k 2023: €590k 2024: €894k
2022 → 2025
Net result
€257k▼ 21.2%
2024 · €326k
2022: €241k 2023: €302k 2024: €326k
2022 → 2025
Working capital
€-42k
2024 · €812k
2022: €237k 2023: €538k 2024: €812k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line2022202320242025Trend
Equity€242k-€543k▲ 125%€869k▲ 60.1%€1k▼ 99.9%
Operating result€317k-€393k▲ 24.1%€414k▲ 5.1%€328k▼ 20.8%
Net result€241k-€302k▲ 25.2%€326k▲ 8.0%€257k▼ 21.2%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€200k€400kOperating result 2022: €317k€317kNet result 2022: €241k€241kOperating result 2023: €393k€393kNet result 2023: €302k€302kOperating result 2024: €414k€414kNet result 2024: €326k€326kOperating result 2025: €328k€328kNet result 2025: €257k€257k2022202320242025€0€200k€400kOperating result 2023: €393k€393kNet result 2023: €302k€302kOperating result 2024: €414k€414kNet result 2024: €326k€326kOperating result 2025: €328k€328kNet result 2025: €257k€257k202320242025
The operating result falls in 2025; 2025 is 21% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €657k
Fixed assets €43k ▼ 25.1%
Current assets €614k ▼ 26.5%
Equity and liabilities €657k
Equity €1k ▼ 99.9%
Debt €656k ▲ 2,562%
Debt's share of the balance-sheet total rises from 2.8% to 99.8%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€342k
2024 · €427k
Cash flow
€272k
2024 · €340k
Current ratio
0.94
2024 · 34.25
ROA
39.1%
2024 · 36.5%
Interest coverage
892.71
2024 · 919.86
Debt ≤ 1 year
€656k
2024 · €24k
Income taxes
€80k
2024 · €104k
A ratio outside any meaningful range has been withheld (balance sheet total €657k, equity €1k).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines
Balance sheet Code20242025
Assets
Total assets20/58€894k€657k
Fixed assets21/28€58k€43k
Tangible fixed assets22/27€58k€43k
Furniture and vehicles24€58k€43k
Current assets29/58€836k€614k
Amounts receivable within one year40/41€116k€121k
Trade receivables40€116k€106k
Other amounts receivable41-€15k
Current investments50/53€352k€442k
Cash at bank and in hand54/58€365k€48k
Deferred charges and accrued income490/1€3k€3k
Equity and liabilities
Total equity and liabilities10/49€894k€657k
Equity10/15€869k€1k
Contributions10/11€1k€1k=
Reserves13€868k€295
Distributable reserves133€868k€295
Amounts payable17/49€25k€656k
Amounts payable within one year42/48€24k€656k
Trade debts44€216-
Suppliers440/4€216-
Taxes, remuneration and social security45€20k€46k
Taxes450/3€20k€46k
Other amounts payable47/48€5k€610k
Accrued charges and deferred income492/3€246€196
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€15k
Other operating charges640/8€148€150
Gross operating margin9900€427k€342k
Operating profit (loss)9901€414k€328k
Financial income75/76B€17k€10k
Recurring financial income75€17k€10k
Financial charges65/66B€464€383
Recurring financial charges65€464€383
Profit (loss) for the period before taxes9903€430k€338k
Income taxes67/77€104k€80k
Profit (loss) for the period9904€326k€257k
Profit (loss) for the period to be appropriated9905€326k€257k
Appropriation of the result
Profit (loss) to be appropriated9906€326k€257k
Transfer from equity791/2-€868k
Transfer to equity691/2€326k€294
To other reserves6921€326k€294
Profit to be distributed694/7-€1.13M
Return on contributions (dividend)694-€1.13M

The notes to these accounts (4 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
10-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
26-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Highest result since 2022net €326k ▲8%
Operating result €414k, net result €326k, both a record.
31-12
Financial Liquidity triplescurrent ratio 34.25
Current ratio from 12.51 to 34.25; short-term debt falls from €47k to €24k.
06-06
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Liquidity doublescurrent ratio 12.51
Current ratio from 5.61 to 12.51; short-term debt falls from €51k to €47k.
31-12
Financial Equity above €500kEq €543k ▲125%
2 profitable years in a row build equity to €543k.
06-06
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Beerse · 1 establishment unit since 2021
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Vossenlaan 192340 Beerse
Ground area
11.6 ha
Building footprint
2.4 ha
Volume, LiDAR
19,471 m³
2 parcels, Flanders · tallest building 18.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
DR. JASPER VICTOOR, PATHOLOOG-ANATOOM
Liersesteenweg 435, 2800 MechelenSpecialist medical practice
since 20212.318.980.978
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
12402E0270/00A002 Flanders 11.4 ha 1 · 2.4 ha 18.4 m
13004C0387/00E016 Flanders 2,362 m² 1 · 197 m² 11.8 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

984500942D9FBBC2E549
live in the LEI register

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded05-07-2021
Fiscal year end31-12
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.